CRISPR-based diagnostics for SARS-CoV-2 detection
  • Reading time:5 min(s) read

In a latest research posted to the Journal of Biochemical and Molecular Toxicology, researchers reviewed clustered repeatedly interspaced quick palindromic repeats (CRISPR)-based diagnostics for detecting extreme acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

Study: CRISPR-based point-of-care diagnostics incorporating Cas9, Cas12, and Cas13 enzymes superior for SARS-CoV-2 detection. Image Credit: Meletios Verras / Shutterstock

The coronavirus illness 2019 (COVID-19) pandemic attributable to SARS-CoV-2 has adversely affected human lives, public well being, and the financial system. Diagnosis of SARS-CoV-2 an infection is by detecting viral nucleic acids (ribonucleic acid [RNA]) or antigens. Although reverse transcription-polymerase chain response (RT-PCR) testing is extensively used for SARS-CoV-2 detection, it’s costly, laborious, and requires expert personnel. These limitations basically mandate the necessity for speedy and correct point-of-care (POC) checks.

In the present evaluation, researchers mentioned CRISPR-based applied sciences, emphasizing three CRISPR-associated (Cas) proteins, specifically Cas9, Cas12, and Cas13, for COVID-19 prognosis.

Diagnostic checks incorporating the CRISPR-Cas9 system

One of the most important Cas9 orthologs is from Francisella novicida (Fn), and the interactions of FnCas9 with deoxy RNA (DNA) primarily contain the 5’-NGG-3’ protospacer adjoining motif (PAM). DNA interrogation by CRSPR-FnCas9 and subsequent cleavage of the DNA duplex serves as an correct and fast methodology for detecting single-nucleotide variants (SNVs), supplied that DNA discrimination is fixed all through the genomic sequence.

This strategy was termed FnCas9 editor-linked uniform detection assay (FELUDA), developed by the Institute of Genomics and Integrative Biology (IGIB) and the Tata group. FELUDA, a paper-based strip check for SARS-CoV-2 authorized in India, requires the identical sampling methodology because the quantitative PCR (qPCR), whereby naso- and oropharyngeal swabs and saliva samples are collected for RNA isolation.

The extracted RNA is topic to an optimized single-step RT-PCR on an ordinary PCR instrument relatively than the high-priced qPCR, and the resultant amplicons are biotinylated. Next, the amplified nucleic acids are combined and incubated with a FELUDA combine comprising information RNA (gRNA) labeled with fluorescent amidite (FAM) and deactivated FnCas9 (dFnCas9).

The Cas9 ribonucleoprotein (RNP) advanced binds to the 20-nucleotide goal particularly if it harbors the signature sequence of SARS-CoV-2. Once the goal sequence is positioned by the RNP advanced, it strikes together with the gold nanoparticles. The nanoparticles seize RNP complexes by adhering to FAM on the three’ finish of the gRNA. These nanoparticles are combined with streptavidin. The nanoparticle-bound FELUDA advanced is captured by the binding of streptavidin-biotin.

The check band (on the strip) can be coloured when the goal viral sequence is current, whereas unbound nanoparticles are captured on the management band. As such, constructive samples end in two bands and detrimental samples in just one band. Evidence means that the assay is 97% delicate and 100% particular with a detection restrict of 10 viral RNA copies/μl. The FELUDA methodology requires minimal technical experience with out expensive devices however is proscribed by the requirement of a thermal cycler.

Using CRISPR-Cas12 system

Cas12 represents an alternative choice to Cas9 given its distinctive traits, just like the absence of trans-activating CRISPR RNA (tracrRNA) and the power to focus on motifs enriched with thymidine. CRISPR-based strategies for SARS-CoV-2 detection usually use Cas12 to determine the viral sequences and depend on isothermal amplification strategies like recombinase polymerase amplification (RPA) and loop-mediated isothermal amplification (LAMP). Further, these strategies are ideally inexpensive given the shortage of a thermal cycler.

The CRISPR-based assay termed ‘DNA endonuclease-targeted CRISPR trans reporter (DETECTR)’ performs concurrent reverse transcription and LAMP (RT-LAMP) adopted by detection of SARS-CoV-2 sequences in an correct, quick and delicate method.

CRISPR-Cas13-based SARS-CoV-2 detection

Specific high-sensitivity enzymatic reporter unlocking (SHERLOCK) is a CRISPR-Cas13-based diagnostic check that contains a detection combine consisting of Cas13a, customized crRNA, and a reporter RNA (RNA sensor) with a quencher and fluorophore. The pattern containing the goal RNA sequence will result in cleavage of reporter RNA ensuing within the launch of fluorophore collaterally. Therefore, fluorescence is an indicator of a constructive check end result.

Moreover, single targets might be detected utilizing industrial lateral circulate units/strips/assays. The detection methodology for these lateral circulate assays makes use of an RNA sensor of some nucleotides on the middle and is labeled with biotin and FAM on the termini. Streptavidin binds to biotin, and an antibody labeled with FAM-specific gold nanoparticles attaches to the RNA sensor close to the fluorophore leading to a darkish purple colour on the check band. Two bands, management and check, point out a constructive check end result, and a detrimental result’s indicated by the presence of solely the management band.

It has been reported that the SHERLOCK assay for SARS-CoV-2 detection is 96% particular and 100% efficient in figuring out the viral sequences. Further, a modified SHERLOCK assay that allows amplification with out PCR is 100% delicate and particular.

One research demonstrated a way bypassing the extraction of nucleic acids from samples. This has been reported as hconsuming unextracted diagnostic samples to obliterate nucleases (HUDSON). Integrating HUDSON and SHERLOCK, researchers have designed a diagnostic instrument termed streamlined highlighting of infections to navigate epidemics (SHINE). SHINE is advantageous over SHERLOCK; in that it’s a single-step process, and fluorescence is detected by a smartphone, making it a scalable and high-throughput instrument permitting automated information evaluation.


While RT-PCR stays the gold commonplace for detecting SARS-CoV-2, it’s essential to develop diagnostic checks that are fast, dependable, correct, and reasonably priced. CRISPR-based diagnostics may probably function viable options to standard PCR testing, and moreover, these checks is also re-designed to detect different pathogens.

Journal reference:

  • CRISPR‐based mostly level‐of‐care diagnostics incorporating Cas9, Cas12, and Cas13 enzymes superior for SARS‐CoV‐2 detection. Verma MK, Roychowdhury S, Sahu BD, Mishra A, Sethi KK. J Biochem & Molecular Tox. 2022, DOI: 10.1002/jbt.23113,

If you are interested in working in a distraction free environment, visit our site Blissful Noises where we provide various sounds and features to help you focus or relax.